Colorectal Cancer Screening: Randomized Trials Are Essential to Support Recommendations

Ann Intern Med. 2022 Jan;175(1):129-130. doi: 10.7326/M21-3770. Epub 2021 Nov 9.

Authors

Michael Bretthauer¹, Robert E Schoen², Amanda J Cross³, Paul F Pinsky⁴

Affiliations

¹ Clinical Effectiveness Research Group, University of Oslo and University of Tromsø, Oslo, Norway.
² Departments of Medicine and Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania.
³ Department of Surgery and Cancer and the School of Public Health, Imperial College London, London, United Kingdom.
⁴ Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.

PMID: 34748373
DOI: 10.7326/M21-3770

No abstract available

Publication types

Editorial
Comment

MeSH terms

Colorectal Neoplasms* / diagnosis
Early Detection of Cancer*
Humans
Occult Blood
Randomized Controlled Trials as Topic

Grants and funding

25004/CRUK_/Cancer Research UK/United Kingdom